Trial intelligence / Profile preview

Phase III study of subcutaneous diclofenac HPBCD for acute pain after impacted third molar extraction

2009-011663-37Phase 3Completed

Sponsor
IBSA Group
Start
May 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of diclofenac in dental postoperative pain (4 arms), sponsored by IBSA Group. Primary endpoint: Pain intensity difference at 1.5 hours. Started May 2009; status: completed.

02

Drugs

diclofenac
03

Conditions

dental postoperative pain

Beyond the preview

Go deeper on 2009-011663-37.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-011663-37.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call